Material-based deployment enhances efficacy of endothelial progenitor cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 38, 2008, Pages 14347-14352

  Silva, Eduardo A ^a,b   Kim, Eun Suk ^c   Hyun, Joon Kong ^d   Mooney, David J ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF PORTO   (Portugal)

^c Chungnam National University   (South Korea)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biomaterial; Cell therapy; Ischemic diseases; Neovascularization; Regenerative medicine

Indexed keywords

VASCULOTROPIN 121;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HINDLIMB; IN VIVO STUDY; LIMB ISCHEMIA; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE INJURY; TISSUE REGENERATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TISSUE SCAFFOLDS;

MURINAE;

EID: 55749108538     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0803873105     Document Type: Article

References (55)

1. Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813-1826.
2. Couzin J, Vogel G (2004) Cell therapy. Renovating the heart. Science 304:192-194.
3. Srivastava D, Ivey KN (2006) Potential of stem-cell-based therapies for heart disease. Nature 441:1097-1099.
4. Assmus B, et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232.
5. Lunde K, et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199-1209.
6. Hou D, et al. (2005) Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 112:I150-156.
7. March KL, Johnstone BH (2004) Cellular approaches to tissue repair in cardiovascular disease: The more we know, the more there is to learn. Am J Physiol 287:H458-H463.
8. Clinical Trials. Available at http://clinicaltrials.gov/. Accessed August 18, 2008.
9. Rosenzweig A (2006) Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355:1274-1277.
10. Hofmann M, et al. (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202.
11. Akar AR, Durdu S, Corapcioglu T, Ozyurda U (2006) Regenerative medicine for cardiovascular disorders-new milestones: Adult stem cells. Artif Organs 30:213-232.
12. Gerecht-Nir S, Cohen S, Ziskind A, Itskovitz-Eldor J (2004) Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng 88:313-320.
13. Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920-926.
14. Sales VL, et al. (2007) Protein precoating of elastomeric tissue-engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells. Circulation 116:I55-I63.
15. Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608-1621.
16. Johnson PC, Mikos AG, Fisher JP, Jansen JA (2007) Strategic directions in tissue engineering. Tissue Eng 13:2827-2837.
17. Fuchs JR, Hannouche D, Terada S, Vacanti JP, Fauza DO (2003) Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg 38:984-987.
18. Koch RJ, Gorti GK (2002) Tissue engineering with chondrocytes. Facial Plast Surg 18:59-68.
19. Hubbell JA (1995) Biomaterials in tissue engineering. Biotechnology (N Y) 13:565-576.
20. Shin H, Jo S, Mikos AG (2003) Biomimetic materials for tissue engineering. Biomaterials 24:4353-4364.
21. Drury JL, Mooney DJ (2003) Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 24:4337-4351.
22. Alsberg E, Anderson KW, Albeiruti A, Rowley JA, Mooney DJ (2002) Engineering growing tissues. Proc Natl Acad Sci USA 99:12025-12030.
23. Kong HJ, Boontheekul T, Mooney DJ (2006) Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc Natl Acad Sci USA 103:18534-18539.
24. Kong HJ, Polte TR, Alsberg E, Mooney DJ (2005) FRET measurements of cell-traction forces and nano-scale clustering of adhesion ligands varied by substrate stiffness. Proc Natl Acad Sci USA 102:4300-4305.
25. Petrie TA, Capadona JR, Reyes CD, Garcia AJ (2006) Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 27:5459-5470.
26. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676.
27. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
28. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
29. Welt FG, Losordo DW (2006) Cell therapy for acute myocardial infarction: Curb your enthusiasm? Circulation 113:1272-1274.
30. Asahara T, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
31. Ingram DA, et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760.
32. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
33. Shi Q, et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367.
34. Yoder MC, et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801-1809.
35. Ingram DA, Caplice NM, Yoder MC (2005) Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106:1525-1531.
36. Ridgway J, et al. (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444:1083-1087.
37. Hill E, Boontheekul T, Mooney DJ (2006) Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci USA 103:2494-2499.
38. Rowley JA, Mooney DJ (2002) Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 60:217-223.
39. Kanczler JM, et al. (2008) The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 29:1892-1900.
40. Krenning G, Dankers PY, Jovanovic D, van Luyn MJ, Harmsen MC (2007) Efficient differentiation of CD14-+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials 28:1470-1479.
41. Thebaud NB, et al. (2007) Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: A pre-requisite for vascular tissue engineering. J Mater Sci Mater Med 18:339-345.
42. Simons M (2005) Angiogenesis: Where do we stand now? Circulation 111:1556-1566.
43. Sieveking DP, Buckle A, Celermajer DS, Ng MK (2008) Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay. J Am Coll Cardiol 51:660-668.
44. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937-942.
45. Suh W, et al. (2005) Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23:1571-1578.
46. Prater DN, Case J, Ingram DA, Yoder MC (2007) Working hypothesis to redefine endothelial progenitor cells. Leukemia 21:1141-1149.
47. Woywodt A, et al. (2006) Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemost 4:671-677.
48. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y (2001) Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98:6390-6395.
49. Sierra-Honigmann MR, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281:1683-1686.
50. Wolk R, Deb A, Caplice NM, Somers VK (2005) Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 183:131-139.
51. Carmeliet P, et al. (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583.
52. Murohara T, et al. (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578.
53. Hur J, et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
54. Bouhadir KH, et al. (2001) Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17:945-950.
55. Thornton AJ, Alsberg E, Albertelli M, Mooney DJ (2004) Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation 77:1798-1803.